2017
An explanatory factor analysis of a brief self-report scale to detect neurocognitive impairment among HIV-positive men who have sex with men and transgender women in Peru
Weikum D, Shrestha R, Ferro EG, Vagenas P, Copenhaver M, Spudich S, Alpert MD, Cabello R, Lama JR, Sanchez J, Altice FL. An explanatory factor analysis of a brief self-report scale to detect neurocognitive impairment among HIV-positive men who have sex with men and transgender women in Peru. AIDS Care 2017, 29: 1297-1301. PMID: 28449599, PMCID: PMC6337065, DOI: 10.1080/09540121.2017.1322681.Peer-Reviewed Original ResearchConceptsHIV-positive menNeuropsychological Impairment ScaleNeurocognitive impairmentTransgender womenAntiretroviral therapyHIV-positive MSMPoor clinical outcomeHIV risk behaviorsClinical care settingsHealth-related outcomesExploratory factor analysisART adherenceClinical outcomesPatient populationCare settingsImpairment ScaleRisk behaviorsImpairmentMenPrincipal axis factoringSelf-report scalesOrthogonal varimax rotationWomenBrief self-report scaleOutcomes
2015
Evidence-based interventions to enhance assessment, treatment, and adherence in the chronic Hepatitis C care continuum
Meyer JP, Moghimi Y, Marcus R, Lim JK, Litwin AH, Altice FL. Evidence-based interventions to enhance assessment, treatment, and adherence in the chronic Hepatitis C care continuum. International Journal Of Drug Policy 2015, 26: 922-935. PMID: 26077144, PMCID: PMC4577454, DOI: 10.1016/j.drugpo.2015.05.002.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsEvidence-based interventionsHepatitis C care continuumInterferon-based HCV treatmentHepatitis C virus (HCV) treatmentHIV-specific interventionsOral treatment regimensVirologic response ratesC virus treatmentHIV treatment cascadeReal-world effectivenessPre-therapeutic evaluationEvidence-based strategiesHCV careHCV treatmentPeer-reviewed journalsTreatment cascadeTreatment initiationMedicine guidelinesTreatment regimensPatient populationTreatment adherenceCare engagementEligible studiesCare continuumHCV assessment
2009
Comparison of Tuberculin Skin Testing Reactivity in Opioid-Dependent Patients Seeking Treatment with Methadone versus Buprenorphine: Policy Implications for Tuberculosis Screening
Schwarz RK, Bruce RD, Ball SA, Herme M, Altice FL. Comparison of Tuberculin Skin Testing Reactivity in Opioid-Dependent Patients Seeking Treatment with Methadone versus Buprenorphine: Policy Implications for Tuberculosis Screening. The American Journal Of Drug And Alcohol Abuse 2009, 35: 439-444. PMID: 20014914, DOI: 10.3109/00952990903447741.Peer-Reviewed Original ResearchConceptsMethadone maintenance treatmentTuberculin skin testingBuprenorphine maintenance treatmentOpioid-dependent patientsTST positivityMaintenance treatmentBMT programRetrospective cohort studyPrimary care settingSimilar high prevalenceCross-sectional analysisEthnic health disparitiesBMT patientsBMT settingCohort studyTuberculosis infectionSkin testingTuberculosis screeningTST resultsMMT programPatient populationPrimary careHigh prevalenceCare settingsPatients
2007
Integration and co-location of HIV/AIDS, tuberculosis and drug treatment services
Sylla L, Bruce RD, Kamarulzaman A, Altice FL. Integration and co-location of HIV/AIDS, tuberculosis and drug treatment services. International Journal Of Drug Policy 2007, 18: 306-312. PMID: 17689379, PMCID: PMC2696234, DOI: 10.1016/j.drugpo.2007.03.001.Peer-Reviewed Original ResearchConceptsInjection drug useSubstance use treatmentDrug usersEffective substance use treatmentTraining Community Health WorkersActive injection drug useUse treatmentIntegrated care delivery systemSpecialist care providersAdverse drug eventsCommunity health workersComplex patient populationInjection drug usersAdverse side effectsDrug treatment servicesDrug-drug interactionsDetection of tuberculosisCare delivery systemHIV/AIDSAntiretroviral medicationsMedication adherencePatient populationDrug eventsHIV epidemicHealth workers